Praxis Precision Medicines
biopharmaceutical company developing therapies for CNS disorders
Based in MA
🤖
AI Overview
With $480K in lobbying spend across 14 quarterly filings, Praxis Precision Medicines is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2023 to 2025.
$480K
Total Spend
3
Years Active
1
Firms Hired
4
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $200K |
| 2024 | $120K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
- •Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development Neurology Drug Program
- •Company introductions, comment letter
- •Company introductions, FDA matters, Promising Pathway Act
- •FDA matters
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.